BTMD: biote Corp. Stock

by  •  • Comments Off on BTMD: biote Corp. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 203.63
Enterprise Value ($M) 287.72
Book Value ($M) -126.82
Book Value / Share -4.09
Price / Book -1.61
NCAV ($M) -158.09
NCAV / Share -5.08
Price / NCAV -1.29

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.05
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.16
Current Ratio 1.50

Balance Sheet (mrq) ($M)
Current Assets 69.98
Assets 101.25
Liabilities 228.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
5 days ago 13G/A Bandera Partners LLC 7.50 32.90
9 days ago 13G BlackRock, Inc. 5.30 0.00
02-14 13G/A Roystone Capital Management LP 6.90 -23.50
02-13 13G/A Boston Partners 2.45 -15.85
02-12 13G/A LMR Partners LLP 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 60,202 469,153 12.83
2024-11-14 39,481 200,129 19.73
2024-11-13 184,738 653,447 28.27
2024-11-12 19,198 97,220 19.75
2024-11-11 10,895 119,216 9.14

(click for more detail)

Similar Companies
BCAB – BioAtla, Inc. BHST – BioHarvest Sciences Inc.
BIOR – Biora Therapeutics, Inc. CADL – Candel Therapeutics, Inc.
CARM – Carisma Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io